EndoPulse is a medical device company developing a new approach to critical cardiac support. The company’s AVA device (Artificial Ventricle in the Aorta) is an expandable, biomimetic ventricle designed to support the heart while working safely in harmony with the body’s physiology, delivering cardiac assistance from outside the heart. EndoPulse aims to improve outcomes for patients with critical cardiac conditions by addressing the known limitations of existing technologies.